Activated protein C in septic shock: a propensity-matched analysis

INTRODUCTION: The use of human recombinant activated protein C (rhAPC) for the treatment of severe sepsis remains controversial despite multiple reported trials. The efficacy of rhAPC remains a matter of dispute. We hypothesized that patients with septic shock who were treated with rhAPC had an impr...

Descripción completa

Detalles Bibliográficos
Autores principales: Sadaka, Farid, O'Brien, Jacklyn, Migneron, Matthew, Stortz, Julie, Vanston, Alexander, Taylor, Robert W
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2011
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3219349/
https://www.ncbi.nlm.nih.gov/pubmed/21385410
http://dx.doi.org/10.1186/cc10089

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3219349/
https://www.ncbi.nlm.nih.gov/pubmed/21385410
http://dx.doi.org/10.1186/cc10089

Ejemplares similares